Question 1

What is autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

Autoimmune lymphoproliferative syndrome type 2B is a very rare genetic condition that causes significant immune dysregulation, manifesting primarily as lymphadenopathy, splenomegaly, and recurrent viral infections, particularly due to herpes viruses. The disorder is caused by pathogenic variants in the CASP8 gene, which plays an important role in regulating programmed cell death and immune responses. Although symptoms typically become apparent in early childhood, the severity and specific features can vary widely between individuals. Overall, this condition is extremely uncommon, affecting fewer than 1 in 1,000,000 people.

Question 2

What are the symptoms of autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

The clinical presentation of autoimmune lymphoproliferative syndrome type 2B includes several characteristic features. Nearly all affected individuals exhibit splenomegaly, eczematoid dermatitis, lymphadenopathy, decreased T cell activation, and recurrent sinopulmonary infections. In addition, patients commonly experience short stature, an absence or near-absence of specific antibody responses following pneumococcal vaccination, asthma, recurrent herpes infections, defective B cell activation, reduced CD95-induced lymphocyte apoptosis, pneumonia, failure to thrive, and an inverted CD4:CD8 ratio. Some may also have decreased circulating levels of IgM, IgG, or IgA or experience chronic diarrhea. Not all individuals experience every feature, and severity varies considerably.

Question 3

What causes autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

Autoimmune lymphoproliferative syndrome type 2B is caused by pathogenic variants in the CASP8 gene, which encodes caspase 8, a key enzyme in apoptosis and immune regulation. The condition is inherited in an autosomal recessive manner, meaning that an affected individual inherits two copies of the altered gene, one from each parent. This disorder is more common when parents share a common ancestor, as the likelihood of both being carriers is increased. Genetic counseling is recommended for families to understand the implications and recurrence risks associated with this condition. Associated genes include CASP8.

Question 4

How is autoimmune lymphoproliferative syndrome type 2B inherited?

Accepted Answer

autoimmune lymphoproliferative syndrome type 2B follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

autoimmune lymphoproliferative syndrome type 2B is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is autoimmune lymphoproliferative syndrome type 2B diagnosed?

Accepted Answer

Definitive diagnosis is achieved through molecular genetic testing that identifies pathogenic variants in the CASP8 gene. Clinical evaluation also plays a critical role, with a focus on the characteristic features such as lymphadenopathy, splenomegaly, and recurrent infections. Because many of these features can be seen in other immunologic conditions, genetic testing is essential to confirm the diagnosis.

Question 7

Are there treatments for autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

Currently, management focuses on supportive care and symptom management. Treatment plans are tailored to the individual and typically involve a multidisciplinary team, with regular surveillance to monitor for emerging complications. As there are no FDA-approved treatments specific to autoimmune lymphoproliferative syndrome type 2B, care is directed towards managing infections, controlling immune dysregulation, and addressing growth and developmental issues. Patients and their families are encouraged to discuss treatment options and potential benefits of genetic counseling with their healthcare team.

Question 8

What complications should we watch for in autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

In autoimmune lymphoproliferative syndrome type 2B, patients may face complications like recurrent infections, particularly from herpes viruses and pneumonia. There can also be issues with growth and development, such as short stature and failure to thrive. It's important to monitor these complications closely with the help of healthcare providers.

Question 9

How does autoimmune lymphoproliferative syndrome type 2B affect daily life?

Accepted Answer

Living with autoimmune lymphoproliferative syndrome type 2B can involve regular medical appointments and monitoring for infections and growth issues. Patients may need to take extra precautions to avoid infections and manage symptoms like eczema or asthma. Supportive care and a tailored treatment plan can help improve daily life.

Question 10

What is the prognosis for someone with autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

The prognosis for individuals with autoimmune lymphoproliferative syndrome type 2B varies widely. Many people can live into adulthood with proper management of their symptoms and complications. Ongoing care and support can help improve outcomes, but the severity of the condition can differ from person to person.

Question 11

Should we consider genetic counseling for autoimmune lymphoproliferative syndrome type 2B?

Accepted Answer

Yes, genetic counseling is recommended for families affected by autoimmune lymphoproliferative syndrome type 2B. It can help you understand the inheritance patterns and risks for future children. A genetic counselor can provide valuable information and support as you navigate this condition.

Organ System	Phenotype Count	Example Features
Lungs and breathing	3	Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine, Asthma, Pneumonia
Blood and immune system	2	Recurrent sinopulmonary infections, Enlarged spleen (splenomegaly)
Growth and development	2	Short stature, Failure to thrive
Digestive system	2	Enlarged spleen (splenomegaly), Chronic diarrhea
Lab test results	1	Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine
Skin	1	Eczematoid dermatitis

Research Type	Count	% of Total
Patient case studies	50	45%
Research summaries	33	30%
Laboratory research	9	8%
Testing and diagnosis research	7	6%
Disease patterns and progression	7	6%
Clinical study results	2	2%
New treatment approaches	2	2%
Other research	1	1%

Kisho

autoimmune lymphoproliferative syndrome type 2B

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

autoimmune lymphoproliferative syndrome type 2B

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is autoimmune lymphoproliferative syndrome type 2B?

What are the symptoms of autoimmune lymphoproliferative syndrome type 2B?

What causes autoimmune lymphoproliferative syndrome type 2B?

How is autoimmune lymphoproliferative syndrome type 2B inherited?

How rare is autoimmune lymphoproliferative syndrome type 2B?

How is autoimmune lymphoproliferative syndrome type 2B diagnosed?

Are there treatments for autoimmune lymphoproliferative syndrome type 2B?

What complications should we watch for in autoimmune lymphoproliferative syndrome type 2B?

How does autoimmune lymphoproliferative syndrome type 2B affect daily life?

What is the prognosis for someone with autoimmune lymphoproliferative syndrome type 2B?

Should we consider genetic counseling for autoimmune lymphoproliferative syndrome type 2B?